Braxia Scientific Corp. (BRAXF)

USD 0.0

(-9.09%)

Long Term Debt Summary of Braxia Scientific Corp.

  • Braxia Scientific Corp.'s latest annual long term debt in 2023 was 131.3 Thousand CAD , down -1.73% from previous year.
  • Braxia Scientific Corp.'s latest quarterly long term debt in 2024 Q3 was 501.03 Thousand CAD , up 1.69% from previous quarter.
  • Braxia Scientific Corp. reported annual long term debt of 133.61 Thousand CAD in 2022, up 174.83% from previous year.
  • Braxia Scientific Corp. reported annual long term debt of 48.61 Thousand CAD in 2021, down 0.0% from previous year.
  • Braxia Scientific Corp. reported quarterly long term debt of 501.03 Thousand CAD for 2024 Q3, up 1.69% from previous quarter.
  • Braxia Scientific Corp. reported quarterly long term debt of 521.66 Thousand CAD for 2024 Q2, up 1.69% from previous quarter.

Annual Long Term Debt Chart of Braxia Scientific Corp. (2023 - 2020)

Historical Annual Long Term Debt of Braxia Scientific Corp. (2023 - 2020)

Year Long Term Debt Long Term Debt Growth
2023 131.3 Thousand CAD -1.73%
2022 133.61 Thousand CAD 174.83%
2021 48.61 Thousand CAD 0.0%
2020 - CAD 0.0%

Peer Long Term Debt Comparison of Braxia Scientific Corp.

Name Long Term Debt Long Term Debt Difference
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 90.641%
CSL Limited 11.23 Billion USD 99.999%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
Evofem Biosciences, Inc. 8000.00 USD -1541.3%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 92.52%
Propanc Biopharma, Inc. 58.64 Thousand USD -123.908%
Mesoblast Limited 100.29 Million USD 99.869%
Marizyme, Inc. 667.12 Thousand USD 80.318%
Genus plc 228.2 Million USD 99.942%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 94.059%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
IMV Inc. 27.39 Million USD 99.521%
AXIM Biotechnologies, Inc. 5.42 Million USD 97.58%
MultiCell Technologies, Inc. 36.43 USD -360328.219%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.764%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 94.101%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 89.311%
Biomind Labs Inc. - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 93.084%
Skye Bioscience, Inc. 171.23 Thousand USD 23.317%
SQZ Biotechnologies Company 20.9 Million USD 99.372%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Intellipharmaceutics International Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.921%
Therapeutic Solutions International, Inc. 5512.00 USD -2282.148%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 59.222%
Alpha Cognition Inc. - USD -Infinity%
argenx SE 15.35 Million USD 99.145%
HST Global, Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD 12.464%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD 20.037%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 99.354%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 76.324%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -419.009%
Endonovo Therapeutics, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
ONE Bio Corp. 592.19 Thousand USD 77.828%
Zenith Capital Corp. 4456.00 USD -2846.679%
Genscript Biotech Corporation 287.12 Million USD 99.954%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -3.96%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 42.735%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD 42.835%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 98.411%
BioStem Technologies, Inc. 265.63 Thousand USD 50.57%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -12240.602%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD 12.238%
Regen BioPharma, Inc. 149.61 Thousand USD 12.238%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD 6.877%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -64.13%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 98.321%
SYBLEU INC 300 Thousand USD 56.232%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 64.421%
Mobile Lads Corp. - USD -Infinity%
International Stem Cell Corporation 445 Thousand USD 70.493%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 98.389%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 71.268%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 88.69%
PureTech Health plc 18.25 Million USD 99.281%
Coeptis Therapeutics, Inc. 150 Thousand USD 12.464%
IXICO plc 275 Thousand USD 52.253%
IntelGenx Technologies Corp. 11.83 Million USD 98.891%
Gelesis Holdings, Inc. 26.3 Million USD 99.501%
CSL Limited 11.23 Billion USD 99.999%
Cellectis S.A. 36.21 Million USD 99.637%